Patents by Inventor Martin Löchelt

Martin Löchelt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF THE FOAMY VIRUS BET PROTEIN FOR INACTIVATING APOBEC
    Publication number: 20110294219
    Abstract: Described is the foamy virus Bet-mediated inactivation of the mutagenic, genome-modifying and vector-inactivating cellular enzyme ABOBEC. Such inactivation is useful for the treatment or prevention of various diseases, e.g., cancer, or for enhancing the production and genetic stability of gene therapy vectors, preferably retroviral vectors.
    Type: Application
    Filed: July 12, 2011
    Publication date: December 1, 2011
    Inventors: Martin Löchelt, Carsten Münk
  • Use Of The Foamy Virus Bet Protein For Inactivating APOBEC
    Publication number: 20090202488
    Abstract: Described is the foamy virus Bet-mediated inactivation of the mutagenic, genome-modifying and vector-inactivating cellular enzyme ABOBEC. Such inactivation is useful for the treatment or prevention of various diseases, e.g., cancer, or for enhancing the production and genetic stability of gene therapy vectors, preferably retroviral vectors.
    Type: Application
    Filed: June 6, 2005
    Publication date: August 13, 2009
    Applicant: DEUTSCHES KREBSFORSCHUNGCZENTRUM
    Inventors: Martin Löchelt, Carsten Münk